Jonathan D Kurtis1,2, Dipak K Raj1,2, Ian C Michelow1,3, Sangshin Park1,3, Christina E Nixon1,2, Emily A McDonald1,3, Christian P Nixon1,2, Sunthorn Pond-Tor1,2, Ambrish Jha1, Ross J Taliano2, Edward R Kabyemela4,5,6, Jennifer F Friedman1,3, Patrick E Duffy7, Michal Fried7. 1. Center for International Health Research, Brown University Medical School, Providence. 2. Department of Pathology and Laboratory Medicine, Brown University Medical School, Providence. 3. Department of Pediatrics, Rhode Island Hospital, Brown University Medical School, Providence. 4. Mother Offspring Malaria Studies (MOMS) Project, Seattle Biomedical Research Institute, Washington. 5. Muheza Designated District Hospital. 6. Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. 7. Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
Abstract
BACKGROUND: In holoendemic areas, children suffer the most from Plasmodium falciparum malaria, yet newborns and young infants express a relative resistance to both infection and severe malarial disease (SM). This relative resistance has been ascribed to maternally-derived anti-parasite immunoglobulin G; however, the targets of these protective antibodies remain elusive. METHODS: We enrolled 647 newborns at birth from a malaria-holoendemic region of Tanzania. We collected cord blood, measured antibodies to Plasmodium falciparum Schizont Egress Antigen-1 (PfSEA-1), and related these antibodies to the risk of severe malaria in the first year of life. In addition, we vaccinated female mice with PbSEA-1, mated them, and challenged their pups with P. berghei ANKA parasites to assess the impact of maternal PbSEA-1 vaccination on newborns' resistance to malaria. RESULTS: Children with high cord-blood anti-PfSEA-1 antibody levels had 51.4% fewer cases of SM compared to individuals with lower anti-PfSEA-1 levels over 12 months of follow-up (P = .03). In 3 trials, pups born to PbSEA-1-vaccinated dams had significantly lower parasitemia and longer survival following a P. berghei challenge compared to pups born to control dams. CONCLUSIONS: We demonstrate that maternally-derived, cord-blood anti-PfSEA-1 antibodies predict decreased risk of SM in infants and vaccination of mice with PbSEA-1 prior to pregnancy protects their offspring from lethal P. berghei challenge. These results identify, for the first time, a parasite-specific target of maternal antibodies that protect infants from SM and suggest that vaccination of pregnant women with PfSEA-1 may afford a survival advantage to their offspring.
BACKGROUND: In holoendemic areas, children suffer the most from Plasmodium falciparummalaria, yet newborns and young infants express a relative resistance to both infection and severe malarial disease (SM). This relative resistance has been ascribed to maternally-derived anti-parasite immunoglobulin G; however, the targets of these protective antibodies remain elusive. METHODS: We enrolled 647 newborns at birth from a malaria-holoendemic region of Tanzania. We collected cord blood, measured antibodies to Plasmodium falciparum Schizont Egress Antigen-1 (PfSEA-1), and related these antibodies to the risk of severe malaria in the first year of life. In addition, we vaccinated female mice with PbSEA-1, mated them, and challenged their pups with P. berghei ANKA parasites to assess the impact of maternal PbSEA-1 vaccination on newborns' resistance to malaria. RESULTS:Children with high cord-blood anti-PfSEA-1 antibody levels had 51.4% fewer cases of SM compared to individuals with lower anti-PfSEA-1 levels over 12 months of follow-up (P = .03). In 3 trials, pups born to PbSEA-1-vaccinated dams had significantly lower parasitemia and longer survival following a P. berghei challenge compared to pups born to control dams. CONCLUSIONS: We demonstrate that maternally-derived, cord-blood anti-PfSEA-1 antibodies predict decreased risk of SM in infants and vaccination of mice with PbSEA-1 prior to pregnancy protects their offspring from lethal P. berghei challenge. These results identify, for the first time, a parasite-specific target of maternal antibodies that protect infants from SM and suggest that vaccination of pregnant women with PfSEA-1 may afford a survival advantage to their offspring.
Authors: O H Branch; V Udhayakumar; A W Hightower; A J Oloo; W A Hawley; B L Nahlen; P B Bloland; D C Kaslow; A A Lal Journal: Am J Trop Med Hyg Date: 1998-02 Impact factor: 2.345
Authors: Michel Cot; Jean Yves Le Hesran; Trine Staalsoe; Nadine Fievet; Lars Hviid; Philippe Deloron Journal: Am J Epidemiol Date: 2003-02-01 Impact factor: 4.897
Authors: Edward R Kabyemela; Michal Fried; Jonathan D Kurtis; Theonest K Mutabingwa; Patrick E Duffy Journal: J Infect Dis Date: 2008-07-15 Impact factor: 5.226
Authors: Helga K Einarsdottir; Nigel M Stapleton; Sicco Scherjon; Jan Terje Andersen; Theo Rispens; C Ellen van der Schoot; Gestur Vidarsson Journal: PLoS One Date: 2014-09-24 Impact factor: 3.240
Authors: Arlene E Dent; Indu Malhotra; Xuelie Wang; Denise Babineau; Kee Thai Yeo; Timothy Anderson; Rhonda J Kimmel; Evelina Angov; David E Lanar; David Narum; Sheetij Dutta; Jack Richards; James G Beeson; Brendan S Crabb; Alan F Cowman; Toshihiro Horii; Eric Muchiri; Peter L Mungai; Christopher L King; James W Kazura Journal: Clin Vaccine Immunol Date: 2015-12-09
Authors: Sangshin Park; Christina E Nixon; Olivia Miller; Nam-Kyong Choi; Jonathan D Kurtis; Jennifer F Friedman; Ian C Michelow Journal: J Infect Dis Date: 2020-07-23 Impact factor: 5.226
Authors: Edward R Kabyemela; Michal Fried; Jonathan D Kurtis; Gwamaka Moses; J Patrick Gorres; Atis Muehlenbachs; Patrick E Duffy Journal: Front Immunol Date: 2021-04-30 Impact factor: 7.561
Authors: Sangshin Park; Christina E Nixon; Sunthorn Pond-Tor; Edward R Kabyemela; Michal Fried; Patrick E Duffy; Jonathan D Kurtis; Jennifer F Friedman Journal: Vaccine Date: 2019-07-06 Impact factor: 3.641
Authors: Abigail J Perrin; Claudine Bisson; Peter A Faull; Matthew J Renshaw; Rebecca A Lees; Roland A Fleck; Helen R Saibil; Ambrosius P Snijders; David A Baker; Michael J Blackman Journal: mBio Date: 2021-03-09 Impact factor: 7.867